View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
April 19, 2011

Medtronic and US Hospital Begin Patient Enrolment for Heart Valve Trial

Medtronic and Loyola University Hospital in Illinois, US, have begun patient enrolment for a clinical trial of a non-surgical heart valve replacement. Loyola is among the 40 hospitals participating in the trial, which will involve 1,300 patients and offer an alternatives to open-heart s

By cms admin

Medtronic and Loyola University Hospital in Illinois, US, have begun patient enrolment for a clinical trial of a non-surgical heart valve replacement.

Loyola is among the 40 hospitals participating in the trial, which will involve 1,300 patients and offer an alternatives to open-heart surgery for patients who need aortic heart valves.

The device is being tested on patients with severe aortic stenosis, a condition that occurs when the aortic valve is narrowed, restricting blood flow.

Once in place, the artificial valve performs the function of the diseased valve, allowing flow of oxygen-rich blood into the aorta, the body’s main artery.

The device is approved in more than 40 countries and considered an investigational device in the US.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management